“…Over recent years, several antibodies have been obtained against specific carbohydrate domains within HS (e.g., JM403, 10E4, and HEPSS1), HA, and CS sulfates or against the proteoglycan core proteins such as syndecan, glypican, or perlecan (31, 96 -98, 118, 119). CS and HA have been shown to be present on the endothelium, using an anti-CS antibody and by capitalizing on the proteinbinding properties of hyaluronan with a fluorescent hyaluronan binding protein (HABP), respectively (29,62,118). Although all these techniques have shown the presence of glycocalyx components on the endothelial cells, a considerable part of these studies are done using epifluorescence microscopy, which has major limitations with respect to optical spatial resolution necessary for imaging the luminal endothelial glycocalyx.…”